129 related articles for article (PubMed ID: 36866557)
1. The Application of HPLC-FLD and NMR in the Monitoring of Therapy Efficacy in Alpha-Mannosidosis.
Krchňák M; Kodríková R; Matulová M; Nemčovič M; Uhliariková I; Katrlík J; Šalingová A; Hlavatá A; Juríčková K; Baráth P; Mucha J; Pakanová Z
Front Biosci (Landmark Ed); 2023 Feb; 28(2):39. PubMed ID: 36866557
[TBL] [Abstract][Full Text] [Related]
2. A human lysosomal alpha(1----6)-mannosidase active on the branched trimannosyl core of complex glycans.
Daniel PF; Evans JE; De Gasperi R; Winchester B; Warren CD
Glycobiology; 1992 Aug; 2(4):327-36. PubMed ID: 1421754
[TBL] [Abstract][Full Text] [Related]
3. Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.
Damme M; Morelle W; Schmidt B; Andersson C; Fogh J; Michalski JC; Lübke T
Mol Cell Biol; 2010 Jan; 30(1):273-83. PubMed ID: 19884343
[TBL] [Abstract][Full Text] [Related]
4. Different oligosaccharides accumulate in the brain and urine of a cat with alpha-mannosidosis: structure determination of five brain-derived and seventeen urinary oligosaccharides.
Hård K; Mekking A; Kamerling JP; Dacremont GA; Vliegenthart JF
Glycoconj J; 1991 Feb; 8(1):17-28. PubMed ID: 1668528
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.
Crawley AC; King B; Berg T; Meikle PJ; Hopwood JJ
Mol Genet Metab; 2006; 89(1-2):48-57. PubMed ID: 16807033
[TBL] [Abstract][Full Text] [Related]
6. The substrate-specificity of human lysosomal alpha-D-mannosidase in relation to genetic alpha-mannosidosis.
al Daher S; de Gasperi R; Daniel P; Hall N; Warren CD; Winchester B
Biochem J; 1991 Aug; 277 ( Pt 3)(Pt 3):743-51. PubMed ID: 1872811
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.
Harmatz P; Cattaneo F; Ardigò D; Geraci S; Hennermann JB; Guffon N; Lund A; Hendriksz CJ; Borgwardt L
Mol Genet Metab; 2018 Jun; 124(2):152-160. PubMed ID: 29716835
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study.
Roces DP; Lüllmann-Rauch R; Peng J; Balducci C; Andersson C; Tollersrud O; Fogh J; Orlacchio A; Beccari T; Saftig P; von Figura K
Hum Mol Genet; 2004 Sep; 13(18):1979-88. PubMed ID: 15269179
[TBL] [Abstract][Full Text] [Related]
9. In vitro hydrolysis of oligomannosyl oligosaccharides by the lysosomal alpha-D-mannosidases.
Michalski JC; Haeuw JF; Wieruszeski JM; Montreuil J; Strecker G
Eur J Biochem; 1990 Apr; 189(2):369-79. PubMed ID: 2338081
[TBL] [Abstract][Full Text] [Related]
10. The substrate specificity of bovine and feline lysosomal alpha-D-mannosidases in relation to alpha-mannosidosis.
DeGasperi R; al Daher S; Daniel PF; Winchester BG; Jeanloz RW; Warren CD
J Biol Chem; 1991 Sep; 266(25):16556-63. PubMed ID: 1885586
[TBL] [Abstract][Full Text] [Related]
11. Alpha-mannosidosis: analysis of urinary oligosaccharides with high performance liquid chromatography and diagnosis of a case with unusually mild presentation.
Warner TG; Mock AK; Nyhan WL; O'Brien JS
Clin Genet; 1984 Mar; 25(3):248-55. PubMed ID: 6705257
[TBL] [Abstract][Full Text] [Related]
12. The catabolism of mammalian glycoproteins. Comparison of the storage products in bovine, feline and human mannosidosis.
Abraham D; Blakemore WF; Jolly RD; Sidebotham R; Winchester B
Biochem J; 1983 Dec; 215(3):573-9. PubMed ID: 6661184
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter study.
Guffon N; Konstantopoulou V; Hennermann JB; Muschol N; Bruno I; Tummolo A; Ceravolo F; Zardi G; Ballabeni A; Lund A
J Inherit Metab Dis; 2023 Jul; 46(4):705-719. PubMed ID: 36849760
[TBL] [Abstract][Full Text] [Related]
14. Oral zinc therapy in the treatment of alpha-mannosidosis.
Wong LT; Vallance H; Savage A; Davidson AG; Applegarth D
Am J Med Genet; 1993 Jun; 46(4):410-4. PubMed ID: 8357013
[TBL] [Abstract][Full Text] [Related]
15. Serum and urinary trisaccharides in mannosidosis.
Lott IT; Daniel PF
Neurology; 1981 Sep; 31(9):1159-62. PubMed ID: 7196541
[TBL] [Abstract][Full Text] [Related]
16. A human lysosomal alpha-mannosidase specific for the core of complex glycans.
De Gasperi R; Daniel PF; Warren CD
J Biol Chem; 1992 May; 267(14):9706-12. PubMed ID: 1577805
[TBL] [Abstract][Full Text] [Related]
17. Oligosaccharides accumulated in the bovine beta-mannosidosis kidney.
Jones MZ; Rathke EJ; Gage DA; Costello CE; Murakami K; Ohta M; Matsuura F
J Inherit Metab Dis; 1992; 15(1):57-67. PubMed ID: 1583877
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of novel complex oligosaccharides accumulated in the caprine beta-mannosidosis kidney. Occurrence of tetra- and pentasaccharides containing a beta-linked mannose residue at the nonreducing terminus.
Matsuura F; Jones MZ
J Biol Chem; 1985 Dec; 260(28):15239-45. PubMed ID: 4066670
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of fucose-containing oligosaccharides by high-performance liquid chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Suzuki M; Suzuki A
Biol Chem; 2001 Feb; 382(2):251-7. PubMed ID: 11308023
[TBL] [Abstract][Full Text] [Related]
20. High resolution and high sensitivity methods for oligosaccharide mapping and characterization by normal phase high performance liquid chromatography following derivatization with highly fluorescent anthranilic acid.
Anumula KR; Dhume ST
Glycobiology; 1998 Jul; 8(7):685-94. PubMed ID: 9621109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
